The intersection of the HER2-low subtype with endocrine resistance: the role of interconnected signaling pathways is a research paper published in Frontiers in Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: K22CA241377
National Institutes of Health
Grant: 5K22CA241377-02
Investigating the biology and therapeutic vulnerabilities of ER+ metastatic breast cancer with activating HER2 mutations
FWCI
1.12
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals